Intratumoral administration of circRNA vaccines in subcutaneous NSCLC, melanoma, and CRC xenografts upregulated IFN-γ (>eight-fold) and Granzyme B (>five-fold), reprogramming immunosuppressive microenvironments toward CD8+ T cell-dominated anti-tumor immunity [55]. The gene discussed is CD8A; the disease is neoplasm.